Sinovac Biotech LTD dividend history

Sinovac Biotech LTD paid $3.53bn in dividends in fiscal 2025.

Dividends, buybacks and capital spending

Dividends (TTM): $3.5B
Diluted share count: 0.0%; year over year
Total shareholder yield: 760.2%; dividends 760.2% + buybacks 0.0% of market value
R&D spending: 56.0%; of revenue
Sales & admin spending: 86.3%; of revenue
Days sales outstanding: 271 days; receivables vs revenue

Dividends by fiscal year

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sinovac Biotech LTD: dividends by fiscal year, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Dividends paid	4	3	6	—	—	—	0	0	1,876	247	328	947	3,534
Share buybacks	0	—	—	—	—	—	—	—	—	—	—	—	—
Dividends ÷ net income	19.3%	—	—	—	—	—	0.0%	0.0%	23.1%	>999%	—	>999%	—
Dividends ÷ free cash flow	8.7%	—	—	—	—	—	0.0%	0.0%	12.7%	—	—	—	—

Dividend per share is the amount declared for the fiscal year as stated in the company's filings (including any special dividend), restated for stock splits and checked against the cash dividends paid. Dividends paid and buybacks are cash amounts; the last-twelve-months column can include an extra payment when a quarter-end date moves.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Sinovac Biotech LTD's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Sinovac Biotech LTD.